Plamev Pet is launching its IPO, giving investors the opportunity to participate in the growth of a business that addresses a widespread challenge for pet owners: ensuring high-quality healthcare and dedicated attention for their dogs and cats.
Analyze the listed companyPara mais detalhes, acesse os documentos da oferta
PREÇO DA AÇÃO
INVESTIMENTO MÍNIMO
QTD. MÍNIMA DE AÇÕES
TIPO DE AÇÃO
ABERTURA
VALUATION PRE-MONEY
QTD. DE AÇÕES ATUAL
QTD. DE AÇÕES A EMITIR
CAPITAL SOCIAL À VENDA
R$ 5.429.688,12
Total captado
R$ 5.429.688,12
Total captado
R$ 4.266.673,20
Captação mínima
R$ 7.999.999,92
Captação máxima + Lote adicional
R$ 4.266.673,20
Captação mínima
R$ 7.999.999,92
Captação máxima + Lote adicional
Plamev Pet doubles its growth every year and is the largest independent pet health and care plan provider.
It was selected for the Endeavor Scale Up program. Its executives have over 20 years of market experience.
Plamev Pet is at the beginning of its strongest growth stage and has an aggressive business plan to reach BRL 80 million in revenue by 2024.
Brazil is the sixth-largest pet products and services market in the world, representing an industry with annual revenues of BRL 42 billion, according to Abinpet (Brazilian Association of the Pet Products Industry – 2022 data).
Focusing only on veterinary services (pet vet) and animal care (pet care), the Brazilian market amounts to BRL 8.4 billion.
The relevance of this market is driven by Brazil’s growing pet population, which already surpasses the number of children and adolescents. According to IBGE, there are 149.6 million pets in the country, of which 85.2 million are dogs and cats, compared to 53.7 million children and adolescents. Within this context, the demand for pet health plans is rapidly increasing.
In the United States — the largest pet market in the world (source: Euromonitor and Abinpet) — industry revenues grew 26% per year between 2017 and 2021, while the number of insured pets increased 21.6% annually during the same period.
In Brazil, however, pet health and assistance plans remain an underpenetrated market with significant growth potential. Service penetration is just 0.5%, meaning that only 1 out of every 200 pets has some type of health protection. By contrast, in several European markets this rate can reach 40%.
Today, Plamev Pet is the best-positioned company to scale alongside the expansion of this market, as the largest independent provider of pet health and assistance plans in Brazil. The company has grown through a strategy focused on the Northeast region, an area with high growth potential and limited presence of other players. Plamev’s entry into the Southeast began in Minas Gerais, where it is now headquartered. This represents the opposite path of its main competitor, which concentrates on the South and Southeast (São Paulo and Rio de Janeiro), resulting in minimal market overlap.
Headquartered in Minas Gerais, Plamev Pet is currently present in 9 states and 360 cities nationwide, supported by a consistent expansion plan.
In recent years, Plamev Pet has doubled in size annually, with an average annual growth rate of 104%. Between 2019 and 2022, revenues increased eightfold, rising from BRL 2.3 million to BRL 19.6 million.
Plamev Pet offers pet health and assistance plans through a disruptive, digital-based business model.
With dashboards that allow real-time monitoring of results, the company can make decisions quickly and effectively. As a result, Plamev Pet’s loss ratio is below 50%, compared to the market average of around 70%¹.
The company has made significant investments in developing the Plamev Appet, a tool designed for the daily lives of dogs and cats that literally gives pets a voice. The app has reached approximately 40,000 downloads across different platforms.
Plamev Pet also offers a broad range of plans, accessible to all income levels. Its products are transparent, with no hidden costs or surprises for pet owners.
Plamev Pet is a 100% Brazilian company and was selected to join the 2021 Endeavor Scale Up program, being recognized as one of the country’s leading high-growth companies with strong impact potential.
Its executives bring deep expertise and experience, combined with a proven track record in creating and generating business value.
R$ 89.725.895,00
VALUATION PRE-MONEY
R$ 2.055,00
INVESTIMENTO MÍNIMO
Preferred Shares
TIPO DE AÇÃO
R$ 8,22
PREÇO DA AÇÃO
Plamev Pet is conducting a public equity offering to raise BRL 6.4 million, which will finance its investment plan. The company’s goal is to reach BRL 80 million in gross revenue by 2024.
The proceeds will be primarily allocated to:
-Team Expansion
-Expansion of Sales Channels
-Technical Enhancement in Digital Marketing
-Executive Team
-Data Analytics and Business Intelligence
-Actuarial Technical Enhancement
-Technology and Development Team
-Technology and Systems Services
-Software, AI, and Mobile Development
-Digital Transformation and Processes
Gross Revenue (2022
Average Annual Growth
Lives in the Portfolio (as of July 2023)
The Company does not operate directly in foreign markets; however, part of the inputs used by the accredited network are traded in foreign currency, which exposes the Company to foreign exchange risk.
Difficulties in acquiring new customers and stagnation in the expansion of the network of clinics and veterinary professionals in Brazil may affect the execution of the Company’s growth plans.
The availability, integrity, and stability of the Company’s information systems are essential for its proper functioning, the continuity of its operations, and its growth.
Changes in current tax legislation and shifts in the position of tax authorities regarding the interpretation of such legislation may impact the Company’s activities.
To support business expansion and its strategy to increase the customer base, the Company raises funds from third parties. The Company believes that the relationship between debt and receivables flow is balanced. However, changes in the macroeconomic environment may have an adverse impact on its results.
The sector in which the Company operates may become subject to regulation by public authorities, such as ANS or SUSEP.
This offering has opened an additional lot of BRL 1,599,998.34.
Maximum target amount including the additional lot: BRL 7,999,999.92.
*The information on this page is updated until the closing date of the respective public offering.